GlobeNewswire by notified

Equinor ASA: Share buy-back

Share

Please see below information about transactions made under the share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR).

Date on which the third tranche of the share buy-back programme for 2023 was announced: 26 July 2023.

The duration of the third tranche of the buy-back programme for 2023: 27 July to no later than 26 October 2023.

Size of the 2023 buy-back programme: Up to 94,000,0000 shares, with a maximum total consideration for the third tranche: USD 550,000,000.

From 16 October to 20 October 2023, Equinor ASA has purchased a total of 526,000 own shares at the Oslo Stock Exchange at an average price of NOK 378.1934 per share.

The third tranche of the share buy-back programme for 2023 has now been completed.

Aggregated overview of transactions per day:

DateAggregated volume (number of shares)Weighted average share price (NOK)Total transaction value (NOK)
16 October170,000378.961364,423,421.00
17 October130,000375.876248,863,906.00
18 October100,000379.738037,973,800.00
19 October70,000378.179326,472,551.00
20 October56,000378.500621,196,033.60
Previously disclosed buy-backs under the third tranche of the 2023 programme

16,811,076336.21155,652,076,453.68
Total buy-backs under third tranche of the 2023 programme (accumulated)17,337,076337.48525,851,006,165.28

Following the completion of the above transactions, Equinor ASA owns a total of 45,265,389 own shares, corresponding to 1.51% of Equinor ASA’s share capital, including shares under Equinor’s share savings programme.

This is information that Equinor ASA is obliged to make public pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix:
A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report and available at www.newsweb.no.

Further information from

Investor relations
Bård Glad Pedersen, senior vice president Investor Relations,
+47 918 01 791

Media
Sissel Rinde, vice president Media Relations,
+ 47 412 60 584


Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities27.2.2024 12:04:09 CET | Press release

27.02.24: Borregaard ASA ("Borregaard", OSE ticker: BRG) Borregaard's Board of Directors has issued share options in accordance with the proxy given by the Annual General Meeting held on 18 April 2023. The total number of options issued is 371,000. The options will expire after five years (27 February 2029) and may be exercised in the last two years. The strike price of the options is NOK 199.10. It is based on the volume weighted average share price (VWAP) during the first three trading days after the announcement of the 4th quarter 2023 results with an addition of 10%. The strike price will be adjusted for dividend and other equity transactions. The maximum annual gain is limited to twice the annual base salary for the Chief Executive Officer, and the equivalent to the annual base salary for the other option holders. At least 50% of the proceeds after tax must be used to purchase shares in the company, and the purchased shares will be locked for a period of three years. The members o

Indkaldelse til ordinær generalforsamling i NKT27.2.2024 12:04:01 CET | pressemeddelelse

Selskabsmeddelelse 27. februar 2024 Meddelelse nr. 4 Indkaldelse til ordinær generalforsamling i NKT NKT A/S indkalder til ordinær generalforsamling onsdag den 20. marts 2024 kl. 15.00 (CET), hvor dørene åbner fra kl. 14.30 (CET) på Glostrup Park Hotel, Hovedvejen 41, 2600 Glostrup. Årsrapport, invitation og dagsorden med de fuldstændige forslag inklusive bilag og oversigt over bestyrelseskandidater er vedhæftet. Mere information kan findes på investors.nkt.com/generalforsamling. NKT’s Årsrapport, Bæredygtighedsrapport og Vederlagsrapport for 2023 kan også læses og printes på investors.nkt.com/corporate-governance/statutory-reports. Kontakt Investor Relations: Michael Nass Nielsen, Head of Investor Relations, Tlf: +45 2494 1654 Presse: Pelle Fischer, External Communications Lead, Tlf: +45 2223 5870 Vedhæftede filer Tilmeldingsblanket 2024Bestyrelseskandidater_2024-finalBilag_Vederlagspolitik 2024Dagsorden og fuldstændige forslag 2024Fuldmagt og Brevstemme 2024Invitation 2024NKT indkald

Notice convening the NKT Annual General Meeting27.2.2024 12:04:01 CET | Press release

Company Announcement 27 February 2024 Announcement No. 4 Notice convening the NKT Annual General Meeting The Annual General Meeting of NKT A/S will be held Wednesday 20 March 2024 at 3.00 p.m. (CET) with doors opening from 2.30 p.m. (CET) at Glostrup Park Hotel, Hovedvejen 41, 2600 Glostrup. Attached are the annual report, invitation and agenda with the full contents of proposals and exhibits, including overview of candidates for the Board of Directors. More information can be found at investors.nkt.com/general-meetings. The Annual Report, Sustainability Report and Remuneration Report for 2023 can be found and printed at investors.nkt.com/corporate-governance/statutory-reports. Contact Investor Relations: Michael Nass Nielsen, Head of Investor Relations, tel: +45 2494 1654 Press: Pelle Fischer, External Communications Lead, tel. +45 2223 5870 Attachments NKT_Annual_Report_2023NKT_Remuneration_Report_2023nkt-2023-12-31-enNotice convening the NKT Annual General Meeting 2024Proxy and post

Zymeworks Announces Participation in Upcoming Investor Conferences27.2.2024 12:00:00 CET | Press release

VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: TD Cowen 44th Annual Health Care Conference: Zymeworks’ management will participate in one-on-one meetings and present on March 6th at 11:10 am Eastern Time (ET) in Boston, MA.Barclays 26th Annual Global Healthcare Conference: Zymeworks’ management will participate in one-on-one meetings and a fireside chat on March 14th at 11:45 am ET in Miami, FL. All presentations and webcasts will be available on Zymeworks’ website at http://ir.zymeworks.com/events-and-presentations. About Zymeworks Inc. Zymeworks is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional bio

Philips launches new Azurion neuro biplane system at #ECR2024 to speed up and improve minimally invasive diagnosis and treatment of neurovascular patients27.2.2024 12:00:00 CET | Press release

February 27, 2024 New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced major enhancements to its Image Guided Therapy System – Azurion – with the launch of its new Azurion neuro biplane system. Designed to streamline neurovascular procedures and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility. As healthcare providers strive to deliver high-quality care to patients, at #ECR2024 Philips is partnering with its customers to improve productivity and access to more sustainable healthcare. Minimally invasive procedures enabled by interventional systems like Azurion are a key part of

HiddenA line styled icon from Orion Icon Library.Eye